As the first and only integrated system featuring Dexcom G4
PLATINUM sensing technology with proven accuracy, Animas Vibe allows patients
to view glucose data and administer insulin right from the pump; simplifying
and aiding their ability to make more informed decisions to fine tune insulin
delivery and manage their diabetes.
The Animas Vibe
system provides patients with their latest glucose readings on the pump screen
and a complete view of glucose highs, lows, and rates of change over time. This
information complements fingerstick testing results and can be used to help
guide immediate and long - term insulin delivery therapy adjustments.
measures glucose levels every five minutes and provides real - time glucose
values, as well as trend information. CGM has been shown to improve glycemic
control in adult patients 25 years and older via lower HbA1c levels, less
frequent hypoglycemia, and reduced glucose variability.
"For many people who
are insulin dependent, diabetes is a demanding disease that can require day-
to-day and hour -by-hour management.
We are pleased to
now offer people with diabetes in the U.S. a solution with CGM technology that
provides the ability to make more informed decisions to manage their disease,
which can ultimately improve blood glucose control," said Dr. Brian Levy, Chief
Medical Officer, Animas Corporation.
Animas Vibe also
offers precise insulin dosing with a low basal increment of 0.025 U/hr across
all available ranges (0.025 U/hr to 25.00 U/hr) and a low bolus increment of
0.05 U across all available bolus ranges (0.05 U to 35.00 U). Animas Vibe users
can also personalize dosing by choosing individual insulin - to-carb ratios,
insulin sensitivity factors, and blood glucose targets in 30-minute increments
with up to 12 personal settings.